IVD has been broadly applied in the diagnosis of diseases for the purpose of monitoring drug therapies or determining prognosis. With rich and vast experience in IVD (in vitro diagnostics) antibody development, Creative Biolabs has established a whole series of β-trace protein antibody development services for kidney diseases screening and treatment monitoring, which are important for the design of novel therapeutic strategies.
IVDs (in vitro diagnostics) have been widely applied in the diagnosis of diseases for the purpose of monitoring drug therapies or determining prognosis. With vast experience in IVD antibody development, Creative Biolabs has established a whole series of ADMA (asymmetric dimethylarginine) antibody development services for chronic kidney diseases screening and treatment monitoring.
IVD (in vitro diagnostics) has risen as a new trend in the pharmaceutical industry and has been broadly used in the diagnosis of diseases for monitoring drug therapies and determining prognosis. Now, Creative Biolabs offers a comprehensive series of IVD antibody development services, especially for Glutathione-s-transferases (GSTs). Our technical experts and scientists specialized in IVD are pleased to help you develop novel IVD antibody for GSTs with professional technical support.
As always focus on the field of IVD (in vitro diagnostics) antibody development, Creative Biolabs now offers a full range of Gamma-glutamyltransferase (GGT) antibody development services for kidney disease screening and treatment monitoring. A team of scientists and expert focused on IVD studies are pleased to assist you in your research with a timely and cost-effective method.
IVDs (in vitro diagnostics) have been widely applied in the diagnosis of diseases in order to monitor drug therapies or determine prognosis. With rich and vast experience in IVD antibody development, Creative Biolabs has established a whole series of Alanine aminopeptidase (AAP) antibody development services for kidney diseases screening and treatment monitoring.
Serum RBP4 is a potential biomarker for kidney disease diagnosis and prognosis. As a pioneer in the area of IVD antibody develoment, Creative Biolabs offers a full range of RBP4 antibody development services to aid in kidney disease screening and treatment monitoring.
As a first-in-class service provider in the field of in vitro diagnostic (IVD) antibody development, Creative Biolabs is confident in the discovery and production of IVD antibodies with high specificity and affinity against different disease biomarkers. Especially, we offer IVD antibody development services targeting a potential marker of kidney diseases, alpha-1 microglobulin.
For Research Use Only.
